Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes

KC Wollert, B Fiedler, S Gambaryan, A Smolenski… - …, 2002 - Am Heart Assoc
KC Wollert, B Fiedler, S Gambaryan, A Smolenski, J Heineke, E Butt, C Trautwein…
Hypertension, 2002Am Heart Assoc
NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of
cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP
on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic
effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent
pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the
antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes …
NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes with the NO donor S-nitroso-N-acetyl-d,l-penicillamine (SNAP) (250 μmol/L) or the PKG-selective cGMP analog 8-pCPT–cGMP (500 μmol/L) activated endogenous PKG type I, as shown by the site-specific phosphorylation of vasodilator-stimulated phosphoprotein, a well-characterized PKG substrate. SNAP (250 μmol/L) and 8-pCPT–cGMP (500 μmol/L) modestly attenuated the hypertrophic response to α1-adrenergic stimulation with phenylephrine. Although a high concentration of SNAP (1000 μmol/L) promoted apoptosis in cardiomyocytes, as evidenced by the formation of histone-associated DNA fragments, antihypertrophic concentrations of SNAP (250 μmol/L) and 8-pCPT–cGMP (500 μmol/L) did not promote cell death. Because chronic activation downregulated endogenous PKG I, we explored whether gene transfer of PKG I would enhance the sensitivity of cardiomyocytes to the antihypertrophic effects of NO/cGMP. Indeed, after adenoviral overexpression of PKG Iβ, SNAP (250 μmol/L) and 8-pCPT–cGMP (500 μmol/L) completely suppressed the hypertrophic response to α1-adrenergic stimulation. As observed in noninfected cells, SNAP (250 μmol/L) and 8-pCPT–cGMP (500 μmol/L) did not promote apoptosis in cardiomyocytes overexpressing PKG Iβ. Moreover, overexpression of PKG Iβ did not enhance the proapoptotic effects of 1000 μmol/L SNAP, implying PKG-independent effects of NO on apoptosis. Endogenous PKG I mediates antihypertrophic but not proapoptotic effects of NO in a cell culture model of cardiomyocyte hypertrophy. Adenoviral gene transfer of PKG I selectively enhances the antihypertrophic effects of NO without increasing the susceptibility to apoptosis.
Am Heart Assoc